2 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
Follow Vulvar Neoplasms: new trials by email Literature Review of Vulvar Neoplasms trials Research Report on Vulvar Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor Fludarabine + Cyclophosphamide, HRYZ-T101 TCR-T Cell - Cervical Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 | Unknown | HRYZ Biotech Co. | 17 | 2023-03-21 | 2024-02-02 |
| A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury Tetrahydrobiopterin - Radiation-Induced Dermatitis | Phase 1 | Unknown | West China Second University Hospital | 45 | 2022-03-01 | 2022-02-28 |
Anus Neoplasms (1) · Oropharyngeal Neoplasms (1) · Penile Neoplasms (1) · Radiodermatitis (1) · Squamous Cell Carcinoma of Head and Neck (1) · Uterine Cervical Neoplasms (1) · Vaginal Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Vulvar Diseases (2) · Anus Diseases (1) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Dermatitis (1)
Cyclophosphamide (1) · fludarabine (1) · sapropterin (1)
HRYZ Biotech Co. (1) · West China Second University Hospital (1)
China (2)